With that in mind, we tapped neurologists across the country for their hot take on the things they would never do in the name ...

Scientists have found the region of the brain responsible for a person’s ability to deal with new problems by examining brain-damaged patients.Researchers, led by experts from the National Hospital ...

Time is of the essence when it comes to building your brain’s defenses, especially since it’s generally impossible to reverse ...

THURSDAY, April 17, 2025 (HealthDay News) -- Common medications like aspirin, ibuprofen, statins and beta blockers appear to ...

Artificial intelligence (AI) is transforming neurological research, offering unprecedented opportunities for improving diagnosis, treatment, and management of neurological disorders. China and the USA ...

While melatonin supplements are popular, it's not always clear how much melatonin you should take. Here's what doctors ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Inspired by Alzheimer’s-stricken Glen Campbell, UT Arlington’s Rhonda Winegar explores how music therapy can support ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

An early-initiation telehealth protocol for advanced care planning was feasible and registered a high degree of satisfaction ...